These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6411957)

  • 1. Antitumor activity of cell walls from Brucella abortus.
    Collet B; Martin A; Le Garrec Y; Dubray G; Toujas L
    J Natl Cancer Inst; 1983 Sep; 71(3):529-34. PubMed ID: 6411957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to tumor graft in mice treated with inactivated Brucella abortus cultured in smooth or rough phase.
    Martin A; Toujas L; Le Garrec Y; Dazord L; Amice J
    J Natl Cancer Inst; 1979 Jan; 62(1):123-7. PubMed ID: 102858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemical and immunologic study of the bacterial wall of Brucella abortus 99].
    Tsankova K; Khristoforov L; Nashkov D
    Vet Med Nauki; 1976; 13(6):85-92. PubMed ID: 827848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases.
    Schultz RM; Pavlidis NA; Chirigos MA
    Cancer Res; 1978 Oct; 38(10):3427-31. PubMed ID: 99230
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant activity of the peptidoglycan isolated from the bacterial wall of Brucella abortus 99].
    Tsankova K
    Vet Med Nauki; 1975; 12(10):35-9. PubMed ID: 812253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of physical and chemical factors on the antigenic activity of the cell walls of Brucella abortus 99].
    Tsankova K; Khristoforov L; Nashkov D
    Vet Med Nauki; 1978; 15(4):63-6. PubMed ID: 33483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC; Harms JS; Banai M; Splitter GA
    Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the culture conditions of Brucella abortus on its antitumor properties.
    Collet B; Dazord L; Portoukalian J; Sauvager F; Ruffault A; David C
    Cancer Immunol Immunother; 1983; 14(3):207-8. PubMed ID: 6404552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis.
    Dubray G; Bézard G
    Ann Rech Vet; 1980; 11(4):367-73. PubMed ID: 6802061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.
    Oliveira SC; Zhu Y; Splitter GA
    Immunology; 1994 Dec; 83(4):659-64. PubMed ID: 7875746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Course of chronic brucellosis in mice is not improved by administration of a vaccinal antigen].
    Plommet M; Plommet AM; Bosseray N
    Ann Rech Vet; 1982; 13(2):127-32. PubMed ID: 6820248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme immunoassay for bovine brucellosis using a monoclonal antibody specific for field strains of Brucella abortus.
    Gorrell MD; Milliken GL; Anderson BJ; Pucci A
    Dev Biol Stand; 1984; 56():491-4. PubMed ID: 6436107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brucella and modification of the host response to bacterial and viral infection. Effect of the S-R variation].
    Pilet C; Le Garrec Y
    Dev Biol Stand; 1976; 31():61, 399-407. PubMed ID: 816692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse.
    Bosseray N; Plommet M
    Ann Microbiol (Paris); 1980; 131A(2):157-69. PubMed ID: 7387055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis.
    Wyckoff JH; Potts RD
    Vet Immunol Immunopathol; 2007 Dec; 120(3-4):148-59. PubMed ID: 17904229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of three major polypeptide species and two major polysaccharide species in the Brucella outer membrane.
    Dubray G; Charriaut C
    Ann Rech Vet; 1983; 14(3):311-8. PubMed ID: 6419668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.